Abstract Details

Title A novel, muscle strength-based endpoint for sensitively tracking disease progression in amyotrophic lateral sclerosis.

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P3 - (-)

Poster/Presentation
Number 138

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Toby A. Ferguson, MD (Biogen) PRESENTER	Dr. Ferguson has received personal compensation for serving as an employee of Biogen. Dr. Ferguson has received stock or an ownership interest from Biogen.
Dawei Liu	Dawei Liu has received personal compensation for serving as an employee of Biogen. Dawei Liu has received stock or an ownership interest from Biogen.
Steve W. Han, MD PhD (Takeda Pharmaceuticals)	No disclosure on file
Donald Johns, MD (Axon Guidance LLC)	No disclosure on file

��ɫ��